Tharimmune, Inc. CEO and Director Sireesh Appajosyula Acquires Stock Options

On August 4, 2025, Sireesh Appajosyula, the CEO and Director of Tharimmune, Inc., acquired 90,000 stock options. These options have an exercise price of $1.33 per share and expire on August 4, 2035. Half of the options (45,000) vested immediately on the grant date, while the remaining 45,000 will vest on August 4, 2026. Following this transaction, Appajosyula owns a total of 205,962 shares of Tharimmune's common stock. This acquisition reflects Appajosyula's continued investment in the company and aligns his interests with those of shareholders.